Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/18074942
Conclusion of this study
There was an inverse relationship between body mass and treatment efficacy. In fact a significant weight loss (and leptin reduction) (P < 0.01) was recorded in the myo-inositol group, whereas the placebo group actually increased weight (P < 0.05). These data support a beneficial effect of myo-inositol in women with oligomenorrhea and polycystic ovaries in improving ovarian function.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study